Adage Capital Partners Gp, L.L.C. Ikena Oncology, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 987,900 shares of IKNA stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
987,900
Previous 987,900
-0.0%
Holding current value
$1.71 Million
Previous $1.63 Million
4.85%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IKNA
# of Institutions
61Shares Held
30.6MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.68 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$8.25 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$7.08 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$6.12 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.89 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $62.7M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...